Healthcare Services

Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market Continues To Impact The Growth Of The Oral Solid Dosage Contract Manufacturing Market

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Oral Solid Dosage Contract Manufacturing Market During The Forecast Period?

The oral solid dosage contract manufacturing market has shown significant expansion in recent years. Its value is predicted to increase from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market can be attributed to several factors, such as the increasing need to reduce in-house manufacturing expenditures, the growing complexity of oral solid dosage formulations, rising volumes of generic drug production, restricted internal manufacturing capacity among pharmaceutical companies, and an increasing reliance on third-party Contract Manufacturing Organizations (CMOs).

The oral solid dosage contract manufacturing market size is projected to experience significant growth in the coming years. It is anticipated to expand to $59.05 billion in 2030, showing a compound annual growth rate (CAGR) of 6.7%. The expansion during the forecast period can be attributed to factors such as a growing demand for scalable pharmaceutical manufacturing solutions, an increasing pipeline of oral solid dosage drugs, rising investment in advanced manufacturing technologies, the expansion of pharmaceutical outsourcing in emerging markets, and a heightened need for flexible and rapid production capabilities. Key trends in the forecast period include an increasing tendency for pharmaceutical companies to outsource oral solid dosage manufacturing, a greater demand for high-volume and cost-efficient tablet and capsule production, the growing adoption of modified and controlled release oral solid dosage forms, an enhanced focus on regulatory compliance and quality assurance in contract manufacturing, and a rising preference for comprehensive end-to-end manufacturing and packaging services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Strategic Drivers Are Supporting The Oral Solid Dosage Contract Manufacturing Market Development?

The escalating requirement for generic pharmaceuticals is projected to fuel the expansion of the oral solid dosage contract manufacturing market in the future. These drugs are medicines functionally identical to their brand-name counterparts concerning dosage, strength, safety, performance, quality, and their intended application. This heightened demand for generic medicines stems from factors such as patent expirations, initiatives to control costs, encouraging regulatory policies, and broader access to medical services. Oral solid dosage contract manufacturing plays a vital role in supporting the creation and delivery of generic drugs, utilizing the expertise of contract manufacturers to boost operational effectiveness, cut expenses, guarantee superior production quality, and facilitate faster, more efficient market entry for these products. As an illustration, in 2025, the Food and Drug Administration, a federal agency in the US, indicated that the FDA had approved over 35,000 generic drugs. Furthermore, 9 out of 10 prescriptions are dispensed as generic drugs. Additionally, in November of 2024, the FDA issued more than 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the increased need for generic drugs acts as a primary catalyst for the expansion of the oral solid dosage contract manufacturing market.

How Does Segment Analysis Break Down The Oral Solid Dosage Contract Manufacturing Market Structure?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

What Trends Are Influencing The Oral Solid Dosage Contract Manufacturing Market Outlook?

Leading companies in the oral mucositis market are focusing on developing innovative solutions, such as cryotherapy, which employs cold therapy to minimize damage to oral tissues, thereby reducing the severity and incidence of the condition. Cryotherapy is a medical treatment that utilizes extreme cold to freeze and destroy abnormal or diseased tissue, applicable for conditions like warts, tumors, or injuries. For instance, in February 2024, Chemo Mouthpiece LLC, a US-based medical device company, announced the approval of its chemo mouthpiece device by the Food and Drug Administration, a US-based government agency. This chemo mouthpiece serves as an intraoral ice pack, delivering cryotherapy to the oral cavity of patients undergoing chemotherapy. It proactively manages and treats oral mucositis, a common and painful side effect of chemotherapy.

Which Companies Are Engaged In The Oral Solid Dosage Contract Manufacturing Market Environment?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Access The Complete Oral Solid Dosage Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Is The Primary Market For The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oral Solid Dosage Contract Manufacturing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795